Amplifon focuses on global hearing care, shares in a mature sector peer group
28.06.2026 - 13:57:10 | ad-hoc-news.de
By Julia Schmitt, Sector & Peer Group desk. Reviewed prior to publication on 2026-06-28, 13:56.
Amplifon (IT0004056880) is a global leader in retail hearing care, with shares listed on the Borsa Italiana in Milan in the FTSE MIB index. The company operates more than 9,700 points of sale worldwide, including owned stores and shop-in-shops, positioning the stock within a mature, defensive health-care services segment.
Global position in hearing care
According to Amplifon’s latest annual report, the group generated consolidated revenues of approximately 2.42 billion euros in 2024, reflecting its scale in the hearing care retail market. The company reports operations in 26 countries, including major European markets, North America and Asia-Pacific, which underpins its diversified geographic exposure.
Amplifon competes with listed peers such as Sonova in Switzerland and Demant in Denmark, which also focus on hearing solutions and audiology services. This peer group forms a specialized subsegment within the broader health-care sector, characterized by aging populations and structural demand for hearing aids, rather than short-term cyclical swings.
Analyst view and sector context
MarketScreener data show that Amplifon is covered by multiple European research houses, with a consensus rating in the Buy-to-Hold range and price targets typically framed against its FTSE MIB peers. Sonova and Demant shares trade on SIX Swiss Exchange and Nasdaq Copenhagen respectively, providing international benchmarks for valuation and margin profiles in hearing care.
In sector commentary on hearing solutions, analysts highlight factors such as store productivity, organic growth in units sold, and operating margin stability as key metrics for evaluating these stocks. Amplifon’s position as a retailer and service provider complements the more manufacturing-focused models of Sonova and Demant, creating a differentiated but closely related equity universe.
All news and analysis on the Amplifon shares
Further corporate releases and price data on Amplifon are available via the Amplifon topic page and the company’s investor relations site.
What the company sells
Amplifon’s core business is the sale and fitting of hearing aids and related audiology services, often branded under the Amplifon name in its retail network. The company offers devices from major manufacturers and provides hearing tests, fitting, and aftercare, generating recurring service revenues alongside product sales.
Where the stock trades today
The Amplifon shares (IT0004056880) trade on Borsa Italiana in Milan, quoted in euros; the latest verified price on the exchange’s data pages is used by investors as the reference level for the stock.
Amplifon at a glance
- Company: Amplifon S.p.A.
- ISIN: IT0004056880
- WKN: A1JAG1
- Ticker: AMP
- Trading venue: Borsa Italiana
- Price (as of 2026-06-26, 17:35): 38.50 EUR
- Market cap: 9.6 billion EUR (as of 2026-06-26)
- Sector / industry: Health Care Equipment & Services / Hearing care
- Index membership: FTSE MIB
- Next earnings date: 2026-07-30
Disclaimer: This article is for informational purposes only and does not contain investment advice or recommendations. All data are based on publicly available sources believed to be reliable at the time of review.
